RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo.
about
Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory geneHuman TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation propertiesNRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptorsA new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding proteinPhosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation.Adenovirus E1A functions as a cofactor for retinoic acid receptor beta (RAR beta) through direct interaction with RAR betaThe coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathwaysHuman TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptorsDomain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitroCloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP functionTIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptorsDifferential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1Functional analysis of retinoid Z receptor beta, a brain-specific nuclear orphan receptorThe orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolismStructure, Energetics, and Dynamics of Binding Coactivator Peptide to the Human Retinoid X Receptor α Ligand Binding Domain Complex with 9- cis -Retinoic AcidNew retinoid X receptor subtypes in zebra fish (Danio rerio) differentially modulate transcription and do not bind 9-cis retinoic acidDifferent agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mappingThe T protein encoded by Brachyury is a tissue-specific transcription factorPhosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment.Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA.Retinoic acid receptor alpha1 variants, RARalpha1DeltaB and RARalpha1DeltaBC, define a new class of nuclear receptor isoforms.Binding-folding induced regulation of AF1 transactivation domain of the glucocorticoid receptor by a cofactor that binds to its DNA binding domain.The N-terminal region (A/B) of rat thyroid hormone receptors alpha 1, beta 1, but not beta 2 contains a strong thyroid hormone-dependent transactivation functionDevelopment and evolution of the pharyngeal apparatusCharacterization of the AB (AF-1) region in the muscle-specific retinoid X receptor-gamma: evidence that the AF-1 region functions in a cell-specific mannerThe elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptors.Homo- and heterodimers of the retinoid X receptor (RXR) activated transcription in yeast.Epigenetic regulation by RARα maintains ligand-independent transcriptional activity.Retinoid X receptor alpha transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor.Separation of retinoid X receptor homo- and heterodimerization functionsIn vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia.Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelinationA 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB.Ligand-dependent and -independent transactivation by thyroid hormone receptor beta 2 is determined by the structure of the hormone response element.Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors.The receptor-DNA complex determines the retinoid response: a mechanism for the diversification of the ligand signal.Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism.Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma.Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor
P2860
Q22008489-A5636654-7AF6-467B-A4A7-FF341CD34F7BQ22010399-48D35FE7-6E00-49FD-8F6C-A7118ED898A0Q22010546-5CC8AB6D-F466-4488-AC2D-F8E7DC257B39Q22254332-73EB9366-96A0-4127-BE5F-2412F98EECC7Q24301267-D8BC5E8F-DF19-48A8-A5E3-EDD924D7A26FQ24311404-3C6C609E-AB5D-4856-88E2-75C05A8913C3Q24320338-719A1EC9-0F15-4ED8-A3BC-30F500619F9AQ24324051-C181BF50-6BF4-47A4-A874-004D5147230FQ24514479-8E6800EE-36C3-4363-807E-94F7B0EA0BAEQ24544646-F35D6909-690F-4F29-B0D0-85DD61525798Q24555212-2CD511E9-E9D4-4B26-B8A4-430113CDE716Q24562254-B63D6571-FCA2-4E5F-A605-7E45725AE8A2Q24563324-5AB798A0-BD17-4278-B35A-3ACDE15C4DF2Q24597520-CB28266F-5F60-471A-BB00-15D3263FB008Q24657371-B3CEC8E9-ACD9-4E15-AFC9-D1BC2E0519B6Q27665595-563CB8F8-FF5F-4FEC-A8A5-AE17BBCDE0E5Q28367742-979C6CA4-CF03-4DA3-81DE-5C2C70CA8E4DQ28378417-3CC2C1B8-FD5F-4D6B-9209-0E5BAD20EA69Q28513249-8B02CD01-48DD-4C44-8686-13B3AF3609C7Q33887669-C92C0F89-0EAC-4E17-AFBD-A7788517DA57Q33957795-9D10716D-7B45-4E45-B0C8-AD63890B57CDQ34004662-D8DF3AEC-CE09-4027-B706-AEA6E680CF58Q34049353-8659E1C1-478A-4A52-BD18-FE376CC40E14Q34240655-A2AB5A8A-3629-4A1D-92D0-C6956A79F8FDQ34353382-1C0A52FE-4C65-4298-B483-270DFEE5154CQ34587743-99312E68-9C09-4EA3-802A-5CAF0E3E8CEDQ34769498-CB545DAB-CFFF-4F59-A5AD-B3078E6E41C2Q34808006-4B84475F-4BE8-452E-8DBF-AD48687F278BQ35633556-A96108E8-B19C-4C50-A6E4-86837CDDD722Q35830442-B5BBAF97-F165-4A79-B4E0-627B3C87D6A0Q36139646-C0863C72-7523-48D7-9EF4-2A54BB256C0BQ36228502-DA6A9C67-655A-4F79-91EF-A39FDA5D50CFQ36344854-7C846489-66CD-4784-869C-0AF2269BA15EQ36553911-54C7CB50-9BD6-444C-BF28-D29BC9A08469Q36554199-1E57667B-0F8B-4E7D-9311-966FB0878561Q36555582-5D71866A-D386-41F8-99AC-054558B95D70Q36561262-C6CAF111-A434-4929-A51C-50DF4A0E229CQ36566818-CA997302-3796-422D-BD20-189CFB4ED7B6Q36569469-E10964E0-B63E-4764-A64D-4FC2A269FD2CQ36664756-A5FFD67C-25AC-46DA-9B80-F358C266C40D
P2860
RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
RARs and RXRs: evidence for tw ...... nd heterodimerization in vivo.
@ast
RARs and RXRs: evidence for tw ...... nd heterodimerization in vivo.
@en
RARs and RXRs: evidence for two autonomous transactivation functions
@nl
type
label
RARs and RXRs: evidence for tw ...... nd heterodimerization in vivo.
@ast
RARs and RXRs: evidence for tw ...... nd heterodimerization in vivo.
@en
RARs and RXRs: evidence for two autonomous transactivation functions
@nl
prefLabel
RARs and RXRs: evidence for tw ...... nd heterodimerization in vivo.
@ast
RARs and RXRs: evidence for tw ...... nd heterodimerization in vivo.
@en
RARs and RXRs: evidence for two autonomous transactivation functions
@nl
P2093
P2860
P1433
P1476
RARs and RXRs: evidence for tw ...... nd heterodimerization in vivo.
@en
P2093
P2860
P304
P407
P577
1993-06-01T00:00:00Z